» Authors » Chang-Ling Lin

Chang-Ling Lin

Explore the profile of Chang-Ling Lin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 111
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsieh M, Hsu C, Liao H, Lin C, Chiang C, Chen M, et al.
J Virol . 2024 Feb; 98(2):e0154623. PMID: 38299865
Vaccine-induced mucosal immunity and broad protective capacity against various severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants remain inadequate. Formyl peptide receptor-like 1 inhibitory protein (FLIPr), produced by , can...
2.
Hsieh M, Chen M, Hsu C, Tsai Y, Chiu F, Hsu C, et al.
NPJ Vaccines . 2023 Jun; 8(1):82. PMID: 37268688
Formyl peptide receptor-like 1 inhibitor protein (FLIPr) is an immune evasion protein produced by Staphylococcus aureus, and FLIPr is a potential vaccine candidate for reducing Staphylococcus aureus virulence and biofilm...
3.
Sung J, Hsieh S, Lin C, Leng C, Liu S, Chou A, et al.
Vaccine . 2010 Oct; 28(51):8175-82. PMID: 20937316
Polysaccharide-based vaccines against Neisseria meningitidis (Nm) serogroups A, C, Y and W135 have been available since 1970, but similar vaccine candidates developed for Nm group B (NmB) have not been...
4.
Chen H, Liu S, Liu H, Kwok Y, Lin C, Lin L, et al.
Vaccine . 2009 Jan; 27(9):1400-9. PMID: 19150476
We have developed a novel platform technology that can express high levels of recombinant lipoproteins with intrinsic adjuvant properties. In this study, Ag473 (a lipoprotein from Neisseria meningitidis) can be...
5.
Liu S, Leng C, Lien S, Chi H, Huang C, Lin C, et al.
Vaccine . 2006 Feb; 24(16):3100-8. PMID: 16494977
The recombinant nucleocapsid (rN) protein of the coronavirus (CoV) responsible for severe acute respiratory syndrome (SARS) was cloned and expressed in Escherichia coli, extracted from cell lysates containing 6M urea,...